Merit Medical Systems Inc (MMSI)
81.20
+0.29
(+0.36%)
USD |
NASDAQ |
May 31, 16:00
81.16
-0.04
(-0.05%)
After-Hours: 20:00
Merit Medical Systems Research and Development Expense (TTM): 84.45M for March 31, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 84.45M |
| December 31, 2023 | 84.28M |
| September 30, 2023 | 83.08M |
| June 30, 2023 | 82.65M |
| March 31, 2023 | 86.11M |
| December 31, 2022 | 82.18M |
| September 30, 2022 | 82.15M |
| June 30, 2022 | 79.90M |
| March 31, 2022 | 72.36M |
| December 31, 2021 | 71.25M |
| September 30, 2021 | 66.22M |
| June 30, 2021 | 62.76M |
| March 31, 2021 | 59.19M |
| December 31, 2020 | 57.79M |
| September 30, 2020 | 58.66M |
| June 30, 2020 | 62.14M |
| March 31, 2020 | 64.94M |
| December 31, 2019 | 66.14M |
| September 30, 2019 | 65.52M |
| June 30, 2019 | 63.13M |
| March 31, 2019 | 61.92M |
| December 31, 2018 | 60.18M |
| September 30, 2018 | 57.27M |
| June 30, 2018 | 67.57M |
| March 31, 2018 | 65.34M |
| Date | Value |
|---|---|
| December 31, 2017 | 63.54M |
| September 30, 2017 | 62.66M |
| June 30, 2017 | 49.49M |
| March 31, 2017 | 47.63M |
| December 31, 2016 | 45.69M |
| September 30, 2016 | 45.26M |
| June 30, 2016 | 45.05M |
| March 31, 2016 | 42.73M |
| December 31, 2015 | 41.81M |
| September 30, 2015 | 39.91M |
| June 30, 2015 | 37.08M |
| March 31, 2015 | 37.52M |
| December 31, 2014 | 36.63M |
| September 30, 2014 | 35.93M |
| June 30, 2014 | 34.55M |
| March 31, 2014 | 33.56M |
| December 31, 2013 | 33.89M |
| September 30, 2013 | 32.73M |
| June 30, 2013 | 32.79M |
| March 31, 2013 | 32.74M |
| December 31, 2012 | 30.24M |
| September 30, 2012 | 34.51M |
| June 30, 2012 | 32.54M |
| March 31, 2012 | 29.41M |
| December 31, 2011 | 27.78M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
57.79M
Minimum
Dec 2020
86.11M
Maximum
Mar 2023
71.74M
Average
68.74M
Median
Research and Development Expense (TTM) Benchmarks
| Boston Scientific Corp | 1.444B |
| Becton Dickinson & Co | 1.176B |
| ResMed Inc | 304.81M |
| Stryker Corp | 1.417B |
| West Pharmaceutical Services Inc | 68.90M |